Authors

• Lea Saftić — University Hospital Centre Rijeka, Rijeka, Croatia — ORCID: 0000-0002-3157-1143
• Ružica Višnjovski — University Hospital Centre Rijeka, Rijeka, Croatia — ORCID: 0000-0002-9496-0680
• Dajana Bura-Nekić — University Hospital Centre Rijeka, Rijeka, Croatia — ORCID: 0000-0002-1659-1816
• Marijan Krpan — University Hospital Centre Rijeka, Rijeka, Croatia — ORCID: 0000-0003-2672-0746

Abstract

Acute myocardial infarction is myocardial necrosis caused by interference of the coronary artery. Acute myocardial infarction complicated by cardiogenic shock is quite rare and occurs in only 5-10% of patients who then experience critically decreased myocardial contractility and low cardiac output. The Impella 2.5 with SmartAssist are temporary ventricular support devices and are used in only high-risk percutaneous coronary interventions (1, 2). This paper presents a case study in which Impella implementation is used as a treatment in an urgent acute myocardial infarction case. The Impella 2.5 in conjunction with an Automated Impella Controller reported a great result in the treatment of myocardial infarction complicated by cardiogenic shock in a 51-year-old patient at the University Hospital Centre Rijeka.

Keywords

Impella, acute myocardial infarction, cardiogenic shock

DOI

Literature

1. Møller JE, Kjaergaard J, Terkelsen CJ, Hassager C. Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock. J Clin Med. 2022 April 26;11(9):2427. https://doi.org/10.3390/jcm11092427
2. ABIOMED. (2022) Impella 2.5® Smaller access for unloading the left ventricle. Available at:. https://www.heartrecovery.com/products-and-services/impella/impella-25